Collagen and calcium-binding EGF domain-1 (CCBE1) and neuropilin-2 (NRP2) promote lymphangiogenesis and lymphatic metastasis in CRC and can be used as therapeutic targets in CRC [29–31]. This evidence concerns the gene NRP2 and colorectal carcinoma.